Citigroup »

Spero Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $45k 19k 2.34
2022-09-30 $999 495 2.02
2021-12-31 $527k 33k 16.02
2021-03-31 $1.3M 86k 14.72
2020-12-31 $99k 5.1k 19.40
2020-09-30 $18k 1.6k 11.11
2020-06-30 $40k 3.0k 13.44
2020-03-31 $33k 4.0k 8.16
2019-12-31 $36k 2.4k 14.93
2019-09-30 $19k 1.3k 14.93
2019-06-30 $31k 2.6k 11.70
2019-03-31 $25k 2.0k 12.63
2018-12-31 $14k 2.3k 6.11
2018-09-30 $24k 2.3k 10.35
2018-06-30 $19k 1.3k 14.45
2018-03-31 $11k 802 13.72
2017-12-31 $7.6k 681 11.13